KYVERNA THERAPEUTICS
KYVERNA is pioneering a new class of treatments and potential cures for serious autoimmune diseases. Their therapeutic platform combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the root cause of inflammatory diseases.
KYVERNA THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2018-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.kyvernatx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
110 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Parthenon Therapeutics
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Westlake Village BioPartners
Westlake Village BioPartners investment in Series B - Kyverna Therapeutics
Hudson Bay Capital Management
Hudson Bay Capital Management investment in Series B - Kyverna Therapeutics
RTW Investments LLC
RTW Investments LLC investment in Series B - Kyverna Therapeutics
Vida Ventures
Vida Ventures investment in Series B - Kyverna Therapeutics
The Argentum Group
The Argentum Group investment in Series B - Kyverna Therapeutics
Gilead Sciences
Gilead Sciences investment in Series B - Kyverna Therapeutics
CAM Capital
CAM Capital investment in Series B - Kyverna Therapeutics
Insight Partners
Insight Partners investment in Series B - Kyverna Therapeutics
LYFE Capital
LYFE Capital investment in Series B - Kyverna Therapeutics
Intellia Therapeutics
Intellia Therapeutics investment in Series B - Kyverna Therapeutics
Key Employee Changes
Official Site Inspections
http://www.kyvernatx.com Semrush global rank: 7.27 M Semrush visits lastest month: 548
- Host name: 37.120.75.34.bc.googleusercontent.com
- IP address: 34.75.120.37
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
